Small-scale slaughterhouses (SHs) face many challenges, not least due to the requirements of food safety legislation. Food business operators' (FBOs') own-check system is very important for food safety, but its proper implementation can be quite difficult and laborious for small-scale SHs. In the European Union, the importance not only of food safety but also facilitation of local food production, including small-scale slaughtering, is highlighted. The aim of our study was to assess compliance with legislation of own-check systems, including six own-check programmes and HACCP, in small-scale SHs. The FBOs' opinions of the implementation of own-check systems were also sought to elucidate possible obstacles in implementation. Our results showed that the best compliance in own-check programmes was achieved in temperature of storage rooms and traceability. FBOs also evaluated these programmes as necessary. However, FBOs' perceived necessity of own-check programmes did not always lead to compliance, as was the case with labelling and HACCP. Instead, in HACCP laboriousness and compliance showed a negative correlation (p <0.05). In addition to laboriousness, costs of own-check programmes, specifically concerning microbiological sampling requirements, appeared to influence compliance, with many of the small-scale SHs poorly following sampling requirements. FBOs also noted the high costs of the non-edible by-product programme. Moreover, the results show that official veterinarians' assessment of compliance was significantly higher than that of the researcher, which warrants further investigation. This study reveals that many small-scale SHs in Finland struggle with food safety requirements. Amendments of some of the requirements to ease the burden of FBOs are proposed. HACCP in particular is suggested to be simplified. In addition, ways to improve food safety and official control in small-scale SHs are discussed.

Abstract Background Poor adherence and negative attitudes to treatment are common clinical problems when treating psychotic disorders. This study investigated how schizophrenia core symptoms and daily functioning affect treatment adherence and attitudes toward antipsychotic medication and to compare patients using clozapine or other antipsychotics. Method A cross-sectional study with data from 275 patients diagnosed with schizophrenia spectrum disorder. Patients adherence, attitudes, insight and side-effects were evaluated using the Attitudes toward Neuroleptic Treatment scale. Overall symptomology was measured using the Brief Psychiatric Rating Scale (BPRS), the Health of the Nation Outcome Scale (HoNOS). The functioning was assessed using activities of daily living scale, instrumental activities of daily living scale and social functioning of daily living scale. Results Self-reported treatment adherence was high. Of the patients, 83% reported using at least 75% of the prescribed medication. Having more symptoms was related with more negative attitude towards treatment. There was a modest association with functioning and treatment adherence and attitude toward antipsychotic treatment. Attitudes affected on adherence in non-clozapine but not in clozapine groups. Conclusion Early detection of non-adherence is difficult. Systematic evaluation of attitudes toward the treatment could be one way to assess this problem, along with optimized medication, prompt evaluation of side effects and flexible use of psychosocial treatments.

We study non-compliance in an emissions trading system in which firms may bank and borrow permits. We find a condition involving auditing probability that characterizes compliance and allows us to analyze the time paths of actual emissions, reported emissions and violations. We find two interesting time instants. At the first time instant, reported emissions begin to be lower than the actual emissions, and at the second time instant, the reported emissions become zero and the actual emissions become constant. The results indicate, among other things, that a given penalty scheme may fail to induce compliance over the whole planning interval, even though it achieves compliance over the initial stage.

Asthma and chronic obstructive pulmonary disease (COPD) are major causes of morbidity and mortality worldwide. Optimal control of these conditions is a constant challenge for both physicians and patients. Poor inhaler practice is widespread and is a substantial contributing factor to the suboptimal clinical control of both conditions. The practicality, dependability, and acceptability of different inhalers influence the overall effectiveness and success of inhalation therapy. In this paper, experts from various European countries (Finland, Germany, Hungary, Italy, Poland, Spain, and Sweden) address inhaler selection with special focus on the Easyhaler® device, a high- or medium–high resistance dry-powder inhaler (DPI). The evidence examined indicates that use of the Easyhaler is associated with effective control of asthma or COPD, as shown by the generally accepted indicators of treatment success. Moreover, the Easyhaler is widely accepted by patients, is reported to be easy to learn and teach, and is associated with patient adherence. These advantages help patient education regarding correct inhaler use and the rational selection of drugs and devices. We conclude that switching inhaler device to the Easyhaler may improve asthma and COPD control without causing any additional risks. In an era of climate change, switching from pressurized metered-dose inhalers to DPIs is also a cost-effective way to reduce emissions of greenhouse gases. [MediaObject not available: see fulltext.].